Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a common hormonal disorder in women linked to several health risks and can be managed through various treatments.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

Insulin resistance is strongly linked to higher androgen levels in women with PCOS.

Polycystic Ovarian Syndrome (PCOS) can cause chronic inflammation, mental health issues, and changes in gut bacteria, but a holistic lifestyle change can significantly improve these conditions.

Hair samples can reliably show average long-term hormone levels in young women.

Skin symptoms like fragile skin and easy bruising can indicate Cushing's syndrome, which requires early diagnosis and treatment to prevent serious health issues.

Testosterone affects skin by increasing oil production and influences hair growth.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

Men's fertility and sexual health decline with age, but some remain fertile into their eighties.

Eating dairy and high glycemic foods may increase the risk of acne.

The authors suggest that scalp hair might protect against COVID-19 and call for more research on scalp health and the virus.

Androgenetic alopecia can cause distress and lower quality of life.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hormones like testosterone affect skin functions and can cause skin issues when in excess; treatments to manage these effects are only somewhat effective.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Genetics and hormones cause hair loss; finasteride treats it safely.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Diet, especially dairy and high-sugar foods, can cause acne.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.